Related references
Note: Only part of the references are listed.Environmental enrichment counteracts Alzheimer's neurovascular dysfunction in TgCRND8 mice
Arne Herring et al.
BRAIN PATHOLOGY (2008)
The blood-brain barrier in health and chronic neurodegenerative disorders
Berislav V. Zlokovic
NEURON (2008)
Clearance of amyloid-β by circulating lipoprotein receptors
Abhay Sagare et al.
NATURE MEDICINE (2007)
The role of neuronal signaling in controlling cerebral blood flow
Carrie T. Drake et al.
BRAIN AND LANGUAGE (2007)
Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease
Rashid Deane et al.
CURRENT ALZHEIMER RESEARCH (2007)
Cdk5 is involved in NFT-like tauopathy induced by transient cerebral ischemia in female rats
Yi Wen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2007)
Relation of diabetes to mild cognitive impairment
Jose A. Luchsinger et al.
ARCHIVES OF NEUROLOGY (2007)
Differential changes in phosphorylation of tau at PHF-1 and 12E8 epitopes during brain ischemia and reperfusion in gerbils
W. Gordon-Krajcer et al.
NEUROCHEMICAL RESEARCH (2007)
Soluble protein oligomers in neurodegeneration:: lessons from the Alzheimer's amyloid β-peptide
Christian Haass et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer's phenotype
Nienwen Chow et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Circle of Willis atherosclerosis: association with Alzheimer's disease, neuritic plaques and neurofibrillary tangles
Thomas G. Beach et al.
ACTA NEUROPATHOLOGICA (2007)
Cognitive impact of subcortical vascular and Alzheimer's disease pathology
Helena C. Chui et al.
ANNALS OF NEUROLOGY (2006)
RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease
John E. Donahue et al.
ACTA NEUROPATHOLOGICA (2006)
Major involvement of low-density lipoprotein receptor-related protein 1 in the clearance of plasma free amyloid β-peptide by the liver
Chihiro Tamaki et al.
PHARMACEUTICAL RESEARCH (2006)
APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy
A Rovelet-Lecrux et al.
NATURE GENETICS (2006)
How do heart disease and stroke become risk factors for Alzheimer's disease?
Jack C. de la Torre
NEUROLOGICAL RESEARCH (2006)
P-glycoprotein deficiency at the blood-brain barrier increases amyloid-β deposition in an Alzheimer disease mouse model
JR Cirrito et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Regulation of NMDA receptor trafficking by amyloid-β
EM Snyder et al.
NATURE NEUROSCIENCE (2005)
Dense-core plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls
S Kumar-Singh et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Tau suppression in a neurodegenerative mouse model improves memory function
K SantaCruz et al.
SCIENCE (2005)
Cerebral hypoperfusion and clinical onset of dementia: The Rotterdam study
A Ruitenberg et al.
ANNALS OF NEUROLOGY (2005)
The low density lipoprotein receptor-related protein (LRP) is a novel β-secretase (BACE1) substrate
CAF von Arnim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Neurovascular mechanisms of Alzheimer's neurodegeneration
BV Zlokovic
TRENDS IN NEUROSCIENCES (2005)
Twenty years of the Alzheimer's disease amyloid hypothesis: A genetic perspective
RE Tanzi et al.
CELL (2005)
Neurovascular regulation in the normal brain and in Alzheimer's disease
C Iadecola
NATURE REVIEWS NEUROSCIENCE (2004)
Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins
I Casserly et al.
LANCET (2004)
Method for measurement of the blood-brain barrier permeability in the perfused mouse brain:: application to amyloid-β peptide in wild type and Alzheimer's Tg2576 mice
B LaRue et al.
JOURNAL OF NEUROSCIENCE METHODS (2004)
LRP/amyloid β-peptide interaction mediates differential brain efflux of Aβ isoforms
R Deane et al.
NEURON (2004)
Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis
D Paris et al.
NEUROSCIENCE LETTERS (2004)
The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease
TL Bailey et al.
NEUROLOGICAL RESEARCH (2004)
Amyloid angiopathy-related vascular cognitive impairment
SA Greenberg et al.
STROKE (2004)
RAGE (Yin) versus LRP (Yang) balance regulates Alzheimer amyloid β-peptide clearance through transport across the blood-brain barrier
R Deane et al.
STROKE (2004)
Early-onset and robust cerebral microvascular accumulation of amyloid β-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid β-protein precursor
J Davis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
R Deane et al.
NATURE MEDICINE (2003)
Silent brain infarcts and the risk of dementia and cognitive decline
SE Vermeer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Amyloidosis and Alzheimer's disease
J Ghiso et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Activated protein C:: Potential therapy for severe sepsis, thrombosis, and stroke
JH Griffin et al.
SEMINARS IN HEMATOLOGY (2002)
Circulating amyloid-β peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer's disease lesions
JB Mackic et al.
VASCULAR PHARMACOLOGY (2002)
Substitution at codon 22 reduces clearance of Alzheimer's amyloid-β peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood
OR Monro et al.
NEUROBIOLOGY OF AGING (2002)
Cerebral microvascular pathology in aging and Alzheimer's disease
E Farkas et al.
PROGRESS IN NEUROBIOLOGY (2001)
Clearance of Alzheimer's amyloid-β1-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier
M Shibata et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Patterns of brain activation in people at risk for Alzheimer's disease
SY Bookheimer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Aβ1-40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation
K Niwa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Clearance of amyloid β-peptide from brain:: transport or metabolism?
BV Zlokovic et al.
NATURE MEDICINE (2000)
Share Paper
